Hepatobiliary Events in ≥5000 Patients with Inflammatory Arthritis Treated with Biosimilar or Originator Etanercept in Routine Care, Results from the Danish Nationwide DANBIO Registry

被引：0
|
作者：
Glintborg, Bente [1 ,2 ]
Georgiadis, Stylianos [3 ,4 ]
Norgaard, Mette [5 ]
Mehnert, Frank [5 ]
Gron, Kathrine Lederballe [1 ,2 ]
Krogh, Niels Steen [6 ]
Hetland, Merete Lund [1 ,2 ]
机构：
[1] Rigshosp, Ctr Head & Orthopaed, Ctr Rheumatol & Spine Dis, DANBIO, Copenhagen, Denmark
[2] Rigshosp, Ctr Head & Orthopaed, Ctr Rheumatol & Spine Dis, Copenhagen Ctr Arthrit Res COPECARE, Copenhagen, Denmark
[3] Rigshosp, Ctr Rheumatol & Spine Dis, DANBIO Registry, Copenhagen, Denmark
[4] Rigshosp, Copenhagen Ctr Arthrit Res, Ctr Rheumatol & Spine Dis, Copenhagen, Denmark
[5] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark
[6] DANBIO, Zitelab, Copenhagen, Denmark
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2406
引用
收藏
页数：3
相关论文
共 50 条
  • [1] One-Year Clinical Outcomes in 1623 Patients with Inflammatory Arthritis Who Switched from Originator to Biosimilar Etanercept - an Observational Study from the Danish Danbio Registry
    Glintborg, Bente
    Omerovic, Emina
    Danebod, Kamilla
    Jensen, Dorte Vendelbo
    Nordin, Henrik
    Loft, Anne Gitte
    Chrysidis, Stavros
    Raun, Johnny Lillelund
    Hendricks, Oliver
    Lindegaard, Hanne
    Espesen, Jakob
    Jakobsen, Susanne
    Hansen, Inger Marie J.
    Grydehoj, Jolanta
    Dalgaard, Emil
    Pedersen, Dorte Dalsgaard
    Manilo, Natalia
    Andersen, Lis Smedegaard
    Kristensen, Salome
    Linauskas, Asta
    Krogh, Niels Steen
    Hetland, Merete Lund
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [2] Biosimilar-to-Biosimilar Switching in Routine Care - Results on >1,600 Patients with Inflammatory Arthritis in the DANBIO Registry
    Nabi, Hafsah
    Hendricks, Oliver
    Jensen, Dorte Vendelbo
    Loft, Anne Gitte
    Pedersen, Jens
    Just, Soren
    Danebod, Kamilla
    Munk, Heidi
    Kristensen, Salome
    Manilo, Natalia
    Colic, Ada
    Linauskas, Asta
    Thygesen, Pia Hoger
    Christensen, Louise
    Kalisz, Maren Hogberget
    Lomborg, Niels
    Chrysidis, Stavros
    Raun, Johnny
    Andersen, Marlene
    Mehnert, Frank
    Krogh, Niels Steen
    Hetland, Merete L.
    Glintborg, Bente
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2209 - 2211
  • [3] To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry
    Glintborg, Bente
    Loft, Anne Gitte
    Omerovic, Emina
    Hendricks, Oliver
    Linauskas, Asta
    Espesen, Jakob
    Danebod, Kamilla
    Jensen, Dorte Vendelbo
    Nordin, Henrik
    Dalgaard, Emil Barner
    Chrysidis, Stavros
    Kristensen, Salome
    Raun, Johnny Lillelund
    Lindegaard, Hanne
    Manilo, Natalia
    Jakobsen, Susanne Hojmark
    Hansen, Inger Marie Jensen
    Pedersen, Dorte Dalsgaard
    Sorensen, Inge Juul
    Andersen, Lis Smedegaard
    Grydehoj, Jolanta
    Mehnert, Frank
    Krogh, Niels Steen
    Hetland, Merete Lund
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (02) : 192 - 200
  • [4] CLINICAL OUTCOMES FROM A NATIONWIDE NON-MEDICAL SWITCH FROM ORIGINATOR TO BIOSIMILAR ETANERCEPT IN PATIENTS WITH INFLAMMATORY ARTHRITIS AFTER 5 MONTHS FOLLOW-UP. RESULTS FROM THE DANBIO REGISTRY
    Glintborg, B.
    Sorensen, I. J.
    Loft, A. G.
    Esbesen, J.
    Lindegaard, H.
    Jensen, D. V.
    Danebod, K.
    Dieperink, S.
    Hendricks, .
    Hansen, I. M. J.
    Linauskas, A.
    Kristensen, S.
    Andersen, L. S.
    Hossein, M.
    Nordin, H.
    Andersen, B. L.
    Chrysidis, S.
    Raun, J. L.
    Manila, N.
    Grydehoj, J.
    Dalgaard, E. B.
    Pedersen, D. D.
    Krogh, N. S.
    Hetland, M. L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 553 - 554
  • [5] Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): an observational nationwide study applying linkage between DANBIO and national registries
    Glintborg, Bente
    Georgiadis, Stylianos
    Loft, Anne Gitte
    Linauskas, Asta
    Lindegaard, Hanne
    Hendricks, Oliver
    Jensen, Dorte V.
    Andersen, Birgitte Lange
    Danebod, Kamilla
    Villumsen, Anders
    Eng, Grith
    Wiell, Charlotte
    Manilo, Natalia
    Kristensen, Salome
    Raun, Johnny
    Grydehoj, Jolanta
    Chrysidis, Stavros
    Norgaard, Mette
    Mehnert, Frank
    Krogh, Niels Steen
    Hetland, Merete Lund
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (06) : 846 - 848
  • [6] One-year treatment retention after a nationwide non-medical switch from originator to biosimilar etanercept in 2061 patients with inflammatory arthritis followed in the DANBIO registry
    Glintborg, B.
    Sorensen, I. J.
    Omerovic, E.
    Mehnert, F.
    Manilo, N.
    Danebod, K.
    Jensen, D. V.
    Nordin, H.
    Hendricks, O.
    Loft, A. G.
    Chrysidis, S.
    Andersen, B. L.
    Raun, J. L.
    Lindegaard, H.
    Espesen, J.
    Jakobsen, S. H.
    Hansen, I. J.
    Dalgaard, E. B.
    Pedersen, D. D.
    Kristensen, S.
    Linauskas, A.
    Andersen, L. S.
    Grydehoj, J.
    Krogh, N. S.
    Hetland, M. L.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 : 57 - 58
  • [7] THREE MONTHS' CLINICAL OUTCOMES FROM A NATIONWIDE NON-MEDICAL SWITCH FROM ORIGINATOR TO BIOSIMILAR INFLIXIMAB IN PATIENTS WITH INFLAMMATORY ARTHRITIS. RESULTS FROM THE DANBIO REGISTRY
    Glintborg, B.
    Sorensen, I. Juul
    Jensen, D. Vendelbo
    Krogh, N. S.
    Loft, A. G.
    Colic, A.
    Espesen, J.
    Olsen, J.
    Hendricks, O.
    Grydehoj, J.
    Hansen, I. M. J.
    Sorensen, M. V.
    Chrysidis, S.
    Manilo, N.
    Klarlund, M.
    Andersen, L. S.
    Nordin, H.
    Kristensen, S.
    Hetland, M. L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 142 - 142
  • [8] Three months' clinical outcomes from a nationwide non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis. Results from the DANBIO registry
    Glintborg, B.
    Sorensen, I. J.
    Jensen, D. V.
    Krogh, N. S.
    Loft, A. G.
    Colic, A.
    Espesen, J.
    Olsen, J.
    Hendricks, O.
    Grydehoj, J.
    Hansen, I. M. J.
    Sorensen, M. V.
    Chrysidis, S.
    Linauskas, A.
    Lindegaard, H. M.
    Andersen, B. L.
    Manilo, N.
    Klarlund, M.
    Andersen, L. S.
    Nordin, H.
    Kristensen, S.
    Hetland, M. L.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 : 4 - 5
  • [9] Efficacy of abatacept and tocilizumab in patients with rheumatoid arthritis treated in clinical practice: results from the nationwide Danish DANBIO registry
    Leffers, Henrik Christian
    Ostergaard, Mikkel
    Glintborg, Bente
    Krogh, Niels Steen
    Foged, Heidi
    Tarp, Ulrik
    Lorenzen, Tove
    Hansen, Annette
    Hansen, Michael Sejer
    Jacobsen, Martin Skov
    Dreyer, Lene
    Hetland, Merete Lund
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (07) : 1216 - 1222
  • [10] A Nationwide Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis. Eleven Months' Clinical Outcomes from the Danbio Registry
    Glintborg, Bente
    Sorensen, Inge Juul
    Jensen, Dorte Vendelbo
    Krogh, Niels Steen
    Loft, Anne Gitte
    Espesen, Jakob
    Olsen, Jimmi
    Hendricks, Oliver
    Grydehoj, Jolanta
    Hansen, Inger Marie Jensen
    Sorensen, Michael Veedfald
    Chrysidis, Stavros
    Andersen, Birgitte Lange
    Manilo, Natalia
    Klarlund, Mette
    Andersen, Lis Smedegaard
    Nordin, Henrik
    Kristensen, Salome
    Norregaard, Jesper
    Hetland, Merete Lund
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345